Not independent
Tenure on this board
9.4 yrs
Also a director at
Target Corp (TGT)
3 nominees · 4 ballot items.
Election of three directors; advisory approval of named executive officer compensation (Say-on-Pay); ratification of Ernst & Young LLP as independent auditors; shareholder proposal requesting an independent study on prohibiting corporate contributions to partisan 527 tax-exempt political groups.
Elect three director nominees (Gail K. Boudreaux, Robert L. Dixon, Jr., Deanna D. Strable) to serve three-year terms expiring at the 2029 Annual Meeting.
Non-binding advisory vote to approve the compensation of the company's Named Executive Officers as disclosed in the proxy statement.
Ratify the appointment of Ernst & Young LLP as Elevance Health’s independent registered public accounting firm for the year ending December 31, 2026.
Shareholder proposal requesting the Board commission and publish an independent study examining the impact of adopting a policy prohibiting corporate funds for direct contributions to partisan 527 tax-exempt political groups.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 6.61% | 14,345,459 | $4.2B |
| 2 | STATE STREET CORP | 4.74% | 10,288,696 | $3.0B |
| 3 | WELLINGTON MANAGEMENT GROUP LLP | 3.52% | 7,641,500 | $2.2B |
| 4 | BlackRock, Inc. | 3.14% | 6,826,783 | $2.0B |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.93% | 6,356,077 | $1.9B |
| 6 | Sanders Capital, LLC | 2.71% | 5,894,303 | $1.7B |
| 7 | Artisan Partners Limited Partnership | 2.36% | 5,127,175 | $1.5B |
| 8 | BlackRock, Inc. | 2.20% | 4,772,093 | $1.4B |
| 9 | HARRIS ASSOCIATES L P | 2.15% | 4,658,268 | $1.4B |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.06% | 4,476,367 | $1.3B |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.